Prognostic significance of the CP-GEP assay combining clinicopathologic factors and gene expression profiling in patients (pts) with AJCC v8 stage I/II cutaneous melanoma (CM).

被引：0
|
作者：
Amaral, Teresa Maria Santos
Sinnberg, Tobias
Chatziioannou, Eftychia
Niessner, Heike
Leiter, Ulrike M.
Keim, Ulrike
Forschner, Andrea
Dwarkasing, Jvalini
Meerstein-Kessel, Lisette
Rademaker, Thomas
Wever, Renske
Eggermont, Alexander M.
Flatz, Lukas
Forchhammer, Stephan
机构：
[1] Eberhard Karls Univ Tuebingen, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany
[2] Univ Tubingen, Dept Dermatol & Oncol, Tubingen, Germany
[3] Univ Tubingen, Dept Dermatol, Tubingen, Germany
[4] Eberhard Karls Univ Tuebingen, Dept Dermatol, Tubingen, Germany
[5] SkylineDX BV, Rotterdam, Netherlands
[6] Princess Maxima Ctr Utrecht, Comprehens Canc Ctr Munich, Utrecht, Netherlands
[7] Univ Med Ctr Utrecht, Utrecht, Netherlands
[8] Univ Hosp Tuebingen, Dept Dermatol, Tubingen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9564
引用
收藏
页数：1
相关论文
共 14 条
  • [1] Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)
    Amaral, Teresa
    Sinnberg, Tobias
    Chatziioannou, Eftychia
    Niessner, Heike
    Leiter, Ulrike
    Keim, Ulrike
    Forschner, Andrea
    Dwarkasing, Jvalini
    Tjien-Fooh, Felicia
    Wever, Renske
    Flatz, Lukas
    Eggermont, Alexander
    Forchhammer, Stephan
    EUROPEAN JOURNAL OF CANCER, 2023, 182 : 155 - 162
  • [2] Clinical validation of a prognostic 11-gene assay in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma (CM).
    Garbe, Claus
    Sinnberg, Tobias
    Niessner, Heike
    Suelberg, Heiko
    Eigentler, Thomas K.
    Amaral, Teresa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse
    Mulder, Evalyn E. A. P.
    Johansson, Iva
    Grunhagen, Dirk J.
    Tempel, Dennie
    Rentroia-Pacheco, Barbara
    Dwarkasing, Jvalini T.
    Verver, Danielle
    Mooyaart, Antien L.
    van der Veldt, Astrid A. M.
    Wakkee, Marlies
    Nijsten, Tamar E. C.
    Verhoef, Cornelis
    Mattsson, Jan
    Ny, Lars
    Hollestein, Loes M.
    Bagge, Roger Olofsson
    CANCERS, 2022, 14 (12)
  • [4] Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma
    Amaral, Teresa M. S.
    Hoffmann, Marie-Christine
    Sinnberg, Tobias
    Niessner, Heike
    Suelberg, Heiko
    Eigentler, Thomas K.
    Garbe, Claus
    EUROPEAN JOURNAL OF CANCER, 2020, 125 : 38 - 45
  • [5] Efficacy of adjuvant therapy in patients (pts) with AJCC v8 stage IIIA cutaneous melanoma.
    Grover, Piyush
    Li, Isabel
    Kuijpers, Anke
    Kreidieh, Firas Y.
    Williamson, Andrew
    Amaral, Teresa Maria Santos
    Dimitriou, Florentia
    Placzke, Joanna
    Olino, Kelly
    Vitale, Maria Grazia
    Saiag, Philippe
    Gutzmer, Ralf
    Allayous, Clara
    Bagge, Roger Olofsson
    Asher, Nethanel
    Meniawy, Tarek
    Lawless, Aleigha
    Warburton, Lydia
    Menzies, Alexander M.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Clinical Validation of a prognostic 11-Gene-Expression-Profiling-Score in prospectively collected FFPE Tissue from Patients with cutaneous Melanoma of AJCC v8 Stage II
    Niessner, H.
    Amaral, T.
    Sinnberg, T.
    Suelberg, H.
    Eigentler, T.
    Garbe, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 5 - 6
  • [7] Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanomas
    Niessner, H.
    Sinnberg, T.
    Amaral, T.
    Suelberg, H.
    Eigentler, T.
    Garbe, C.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E34 - E35
  • [8] Risk stratification of patients with stage I cutaneous melanoma (CM) using 31-gene expression profiling (GEP)
    Quick, Ann
    Martin, Brian
    Bailey, Christine
    Covington, Kyle
    Cook, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB110 - AB110
  • [9] Risk stratification of patients with stage I cutaneous melanoma (CM) using 31-gene expression profiling (GEP)
    Quick, A. P.
    Martin, B. J.
    Bailey, C.
    Covington, K. R.
    Cook, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S52 - S52
  • [10] A combined clinicopathologic and gene expression model (CP-GEP) identifies primary cutaneous melanoma patients who can safely forgo sentinel lymph node biopsy
    Meves, Alexander
    Arias-Mejias, Suzette
    Bridges, Alina G.
    Lehman, Julia S.
    Pittelkow, Mark R.
    Cappel, Mark A.
    Perniciaro, Charles
    van Vliet, Martin H.
    Bellomo, Domenico
    Dwarkasing, Jvalini
    Bellomo, Domenico
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB99 - AB99
12